+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Epigenetics Market by Product, Technique, Methods, Application, End User - Global Forecast 2025-2030- Product Image
Epigenetics Market by Product, Technique, Methods, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Epigenetics Market by Product, Technique, Methods, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5665871
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Epigenetics Market grew from USD 3.71 billion in 2023 to USD 4.10 billion in 2024. It is expected to continue growing at a CAGR of 10.82%, reaching USD 7.63 billion by 2030.

Epigenetics, the study of heritable changes in gene expression that do not involve alterations to the underlying DNA sequence, has emerged as a transformative field in genetics and medicine. The necessity of epigenetic research stems from its potential to unlock insights into complex diseases, such as cancer, cardiovascular diseases, and neurological disorders, thereby providing avenues for personalized medicine and targeted therapies. The application of epigenetics extends to drug discovery and development, disease diagnostics, and agriculture, where it helps in crop improvement and stress resistance. End-use scopes primarily include pharmaceutical and biotechnology industries, academic and research institutions, and agriculture sectors. Market growth is significantly influenced by increasing government funding, technological advancements in epigenetic tools, and a heightened focus on precision medicine. Latest potential opportunities arise from exploring epigenetic biomarkers for early disease detection and developing epigenome-editing tools for therapeutic purposes. Companies might capitalize on these opportunities through strategic partnerships and increased investment in R&D for innovative product development. However, challenges such as high costs of epigenetic research and limited understanding of complex biological processes can impede market expansion. Furthermore, ethical concerns regarding gene editing and privacy issues related to genetic data pose additional hurdles. Despite these obstacles, there is substantial growth potential in advancing epigenetic therapeutics and diagnostics. Innovations may target enhancing the accuracy and efficiency of epigenome mapping technologies or developing cost-effective, non-invasive diagnostic tools. The market is characterized by rapid innovation, a competitive landscape with both established and emerging players, and continuous evolution as new findings in epigenetic research are translated into practical applications. In conclusion, businesses aiming for growth in the epigenetics market should focus on cutting-edge research initiatives, address ethical and technical challenges, and pursue collaborations to enhance technological capabilities and global market reach.

Understanding Market Dynamics in the Epigenetics Market

The Epigenetics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Significant growth in the prevalence of chronic and genetic disorders worldwide
    • Favorable governmental initiatives and investments in drug discovery and development
    • Growing inclination toward personalized medicines
  • Market Restraints
    • High cost of development of epigenetics technologies
  • Market Opportunities
    • Ongoing research and development activities for the advancement of epigenetics
    • Expanding the application of epigenetics in non-oncology fields
  • Market Challenges
    • Lack of awareness and limited application of epigenetics

Exploring Porter’s Five Forces for the Epigenetics Market

Porter’s Five Forces framework further strengthens the insights of the Epigenetics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Epigenetics Market

External macro-environmental factors deeply influence the performance of the Epigenetics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Epigenetics Market

The Epigenetics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Epigenetics Market

The Epigenetics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the Epigenetics Market, highlighting leading vendors and their innovative profiles. These include Diagenode S.A. by Hologic, Inc., STORM Therapeutics LTD, Qiagen N.V., Integrated DNA Technologies, Inc. by Danaher Corporation, Active Motif, Inc., Merck KGaA, Novogene Co, Ltd., GenomeScan, Thermo Fisher Scientific Inc., Abnova Corporation, New England Biolabs, Inc., Epigenic Therapeutics, Ipsen, Twist Bioscience Corporation, F. Hoffmann-La Roche Ltd., AstraZeneca PLC, GenScript Biotech Corporation, Exact Sciences Corporation, FOXO Technologies Inc., Watchmaker Genomics, Inc., Chroma Medicine, Inc., Cambridge Epigenetix Ltd., Bristol-Myers Squibb Company, EpiCypher, Inc., Omega Therapeutics, Inc., Promega Corporation, Bioneer Corporation, PerkinElmer, Inc., Gilead Sciences, Inc., Eurofins Scientific SE, ProteoGenix SAS, Abcam PLC, BioCat GmbH by AddLife AB, Creative Diagnostics, EpiGentek Group Inc., Lonza Group Ltd., Zenith Epigenetics Ltd., Agilent Technologies, Inc., BPS Bioscience, Inc., Fios Genomics Ltd., Creative Biogene, Sound Agriculture Company, Takara Holdings Inc., Illumina, Inc., Elysium Health, Inc., Pacific Biosciences of California, Inc, Cusabio Technology LLC, Zymo Research Corporation, Bayer AG, Bio-Rad Laboratories, Inc., and MorphoSys AG.

Market Segmentation & Coverage

This research report categorizes the Epigenetics Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Enzymes
      • DNA-Modifying Enzymes
      • Protein-Modifying Enzymes
    • Instruments & Accessories
    • Reagents & Kits
      • 5-hmC & 5-mC Analysis Kit
      • Antibodies
      • Bisulfite Conversion Kits
      • ChiP-seq Kits
      • Histones
      • Whole Genome Amplification Kits
    • Service
    • Software
  • Technique
    • Mass Spectrometry
    • Next-Generation Sequencing
    • Polymerase Chain Reaction & quantitative Polymerase Chain Reaction
    • Sonication
  • Methods
    • DNA Methylation
    • Histone Modifications
  • Application
    • Cardiovascular Diseases
    • Developmental Biology
    • Immunology
    • Metabolic Diseases
    • Oncology
  • End User
    • Academic & Research Institutes
    • Contract Research Organizations
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Significant growth in the prevalence of chronic and genetic disorders worldwide
5.1.1.2. Favorable governmental initiatives and investments in drug discovery and development
5.1.1.3. Growing inclination toward personalized medicines
5.1.2. Restraints
5.1.2.1. High cost of development of epigenetics technologies
5.1.3. Opportunities
5.1.3.1. Ongoing research and development activities for the advancement of epigenetics
5.1.3.2. Expanding the application of epigenetics in non-oncology fields
5.1.4. Challenges
5.1.4.1. Lack of awareness and limited application of epigenetics
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing usage of reagents & kits for epigenetic research
5.2.2. Technique: Expanding adoption of next-generation sequencing for genome-wide methylation profiling
5.2.3. Methods: Rising utilization of DNA methylation for X-chromosome inactivation
5.2.4. Application: Increasing application of epigenetic tools in oncology
5.2.5. End-User: Growing need for epigenetic tools from academic & research institutes
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Epigenetics Market, by Product
6.1. Introduction
6.2. Enzymes
6.2.1. DNA-Modifying Enzymes
6.2.2. Protein-Modifying Enzymes
6.3. Instruments & Accessories
6.4. Reagents & Kits
6.4.1. 5-hmC & 5-mC Analysis Kit
6.4.2. Antibodies
6.4.3. Bisulfite Conversion Kits
6.4.4. ChiP-seq Kits
6.4.5. Histones
6.4.6. Whole Genome Amplification Kits
6.5. Service
6.6. Software
7. Epigenetics Market, by Technique
7.1. Introduction
7.2. Mass Spectrometry
7.3. Next-Generation Sequencing
7.4. Polymerase Chain Reaction & quantitative Polymerase Chain Reaction
7.5. Sonication
8. Epigenetics Market, by Methods
8.1. Introduction
8.2. DNA Methylation
8.3. Histone Modifications
9. Epigenetics Market, by Application
9.1. Introduction
9.2. Cardiovascular Diseases
9.3. Developmental Biology
9.4. Immunology
9.5. Metabolic Diseases
9.6. Oncology
10. Epigenetics Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Contract Research Organizations
10.4. Pharmaceutical & Biotechnology Companies
11. Americas Epigenetics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Epigenetics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Epigenetics Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Zenith and Cencora Partner to Expedite ZEN-3694 Programme
14.3.2. FOXO, DataRobot Partner for AI-Based Epigenetic Biomarker Research
14.3.3. Zymo Research and Opentrons Partner to Automate Novel Cell-Free DNA Isolation Chemistry
14.3.4. MSU biochemist Receives USD 2.8 million NIH Grant For Epigenetic Research on Autism Spectrum Disorder
14.3.5. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
14.3.6. AstraZeneca Advances its Pipeline and Highlights Progress in Immuno-Oncology, ADCs, Cell Therapy and Epigenetics At AACR
14.3.7. Biomodal Releases Genetics And Epigenetics Solution
14.3.8. Chroma Medicine Raises Stakes in Epigenetic Editing
14.3.9. Ipsen to Acquire Epizyme, Expanding its Portfolio in Oncology
14.3.10. Zenith Epigenetics Announces Start of Several National Cancer Institute (NCI)-Sponsored Oncology Clinical Trials
List of Figures
FIGURE 1. EPIGENETICS MARKET RESEARCH PROCESS
FIGURE 2. EPIGENETICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL EPIGENETICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2023 VS 2030 (%)
FIGURE 11. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. EPIGENETICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. EPIGENETICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. EPIGENETICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL EPIGENETICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. EPIGENETICS MARKET DYNAMICS
TABLE 7. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL EPIGENETICS MARKET SIZE, BY DNA-MODIFYING ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL EPIGENETICS MARKET SIZE, BY PROTEIN-MODIFYING ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL EPIGENETICS MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL EPIGENETICS MARKET SIZE, BY 5-HMC & 5-MC ANALYSIS KIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL EPIGENETICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL EPIGENETICS MARKET SIZE, BY BISULFITE CONVERSION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL EPIGENETICS MARKET SIZE, BY CHIP-SEQ KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL EPIGENETICS MARKET SIZE, BY WHOLE GENOME AMPLIFICATION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL EPIGENETICS MARKET SIZE, BY SERVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL EPIGENETICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL EPIGENETICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL EPIGENETICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL EPIGENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION & QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL EPIGENETICS MARKET SIZE, BY SONICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL EPIGENETICS MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONE MODIFICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL EPIGENETICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL EPIGENETICS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL EPIGENETICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL EPIGENETICS MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL EPIGENETICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL EPIGENETICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL EPIGENETICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL EPIGENETICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. CANADA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. CANADA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 65. CANADA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 66. CANADA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 67. CANADA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 68. CANADA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. CANADA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. MEXICO EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. MEXICO EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 72. MEXICO EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 73. MEXICO EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 75. MEXICO EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. MEXICO EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 95. AUSTRALIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 96. AUSTRALIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 97. AUSTRALIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. CHINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. CHINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 102. CHINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 103. CHINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 104. CHINA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 105. CHINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. CHINA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. INDIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. INDIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 109. INDIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 110. INDIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 111. INDIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 112. INDIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. INDIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. INDONESIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 116. INDONESIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 117. INDONESIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 118. INDONESIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 119. INDONESIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. INDONESIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. JAPAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. JAPAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 123. JAPAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 124. JAPAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 125. JAPAN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 126. JAPAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. JAPAN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. MALAYSIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 130. MALAYSIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 131. MALAYSIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 132. MALAYSIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 133. MALAYSIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. MALAYSIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. PHILIPPINES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 137. PHILIPPINES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 138. PHILIPPINES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 139. PHILIPPINES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 140. PHILIPPINES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. PHILIPPINES EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. SINGAPORE EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 144. SINGAPORE EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 145. SINGAPORE EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 146. SINGAPORE EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 147. SINGAPORE EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. SINGAPORE EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. SOUTH KOREA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 151. SOUTH KOREA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 152. SOUTH KOREA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 153. SOUTH KOREA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 154. SOUTH KOREA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. SOUTH KOREA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. TAIWAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 158. TAIWAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 159. TAIWAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 160. TAIWAN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 161. TAIWAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. TAIWAN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. THAILAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. THAILAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 165. THAILAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 166. THAILAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 167. THAILAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 168. THAILAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. THAILAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. VIETNAM EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 172. VIETNAM EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 173. VIETNAM EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 174. VIETNAM EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 175. VIETNAM EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. VIETNAM EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 185. DENMARK EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. DENMARK EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 187. DENMARK EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 188. DENMARK EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 189. DENMARK EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 190. DENMARK EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. DENMARK EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. EGYPT EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. EGYPT EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 194. EGYPT EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 195. EGYPT EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 196. EGYPT EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 197. EGYPT EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. EGYPT EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. FINLAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. FINLAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 201. FINLAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 202. FINLAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 203. FINLAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 204. FINLAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. FINLAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. FRANCE EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 207. FRANCE EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 208. FRANCE EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 209. FRANCE EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 210. FRANCE EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 211. FRANCE EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. FRANCE EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. GERMANY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. GERMANY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 215. GERMANY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 216. GERMANY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 217. GERMANY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 218. GERMANY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. GERMANY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. ISRAEL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 222. ISRAEL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 223. ISRAEL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 224. ISRAEL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 225. ISRAEL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. ISRAEL EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. ITALY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. ITALY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 229. ITALY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 230. ITALY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 231. ITALY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 232. ITALY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. ITALY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. NIGERIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. NORWAY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 249. NORWAY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 250. NORWAY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 251. NORWAY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 252. NORWAY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 253. NORWAY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. NORWAY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. POLAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 256. POLAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 257. POLAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 258. POLAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 259. POLAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 260. POLAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. POLAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. QATAR EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 263. QATAR EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 264. QATAR EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 265. QATAR EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 266. QATAR EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 267. QATAR EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. QATAR EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 272. RUSSIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 273. RUSSIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 274. RUSSIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. RUSSIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 286. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 288. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. SPAIN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 291. SPAIN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 292. SPAIN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 293. SPAIN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 294. SPAIN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 295. SPAIN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 296. SPAIN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 305. SWITZERLAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 306. SWITZERLAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 307. SWITZERLAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 308. SWITZERLAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 309. SWITZERLAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. SWITZERLAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. TURKEY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 312. TURKEY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 313. TURKEY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 314. TURKEY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 315. TURKEY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 316. TURKEY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 317. TURKEY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 326. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 328. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 329. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 330. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 331. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 332. EPIGENETICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 333. EPIGENETICS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Epigenetics market, which are profiled in this report, include:
  • Diagenode S.A. by Hologic, Inc.
  • STORM Therapeutics LTD
  • Qiagen N.V.
  • Integrated DNA Technologies, Inc. by Danaher Corporation
  • Active Motif, Inc.
  • Merck KGaA
  • Novogene Co, Ltd.
  • GenomeScan
  • Thermo Fisher Scientific Inc.
  • Abnova Corporation
  • New England Biolabs, Inc.
  • Epigenic Therapeutics
  • Ipsen
  • Twist Bioscience Corporation
  • F. Hoffmann-La Roche Ltd.
  • AstraZeneca PLC
  • GenScript Biotech Corporation
  • Exact Sciences Corporation
  • FOXO Technologies Inc.
  • Watchmaker Genomics, Inc.
  • Chroma Medicine, Inc.
  • Cambridge Epigenetix Ltd.
  • Bristol-Myers Squibb Company
  • EpiCypher, Inc.
  • Omega Therapeutics, Inc.
  • Promega Corporation
  • Bioneer Corporation
  • PerkinElmer, Inc.
  • Gilead Sciences, Inc.
  • Eurofins Scientific SE
  • ProteoGenix SAS
  • Abcam PLC
  • BioCat GmbH by AddLife AB
  • Creative Diagnostics
  • EpiGentek Group Inc.
  • Lonza Group Ltd.
  • Zenith Epigenetics Ltd.
  • Agilent Technologies, Inc.
  • BPS Bioscience, Inc.
  • Fios Genomics Ltd.
  • Creative Biogene
  • Sound Agriculture Company
  • Takara Holdings Inc.
  • Illumina, Inc.
  • Elysium Health, Inc.
  • Pacific Biosciences of California, Inc
  • Cusabio Technology LLC
  • Zymo Research Corporation
  • Bayer AG
  • Bio-Rad Laboratories, Inc.
  • MorphoSys AG

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4.1 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.63 Billion
Compound Annual Growth Rate10.8%
Regions CoveredGlobal
No. of Companies Mentioned52

Related Topics

Related Reports

Epigenetics Market Size, Share & Trends Analysis Report By Product (Reagents, Kits, Instruments), By Technology (DNA Methylation), By Application (Oncology), By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Epigenetics Market Size, Share & Trends Analysis Report By Product (Reagents, Kits, Instruments), By Technology (DNA Methylation), By Application (Oncology), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Epigenetics Market Report by Product, Technology, Application, and Region 2024-2032 - Product Image

Epigenetics Market Report by Product, Technology, Application, and Region 2024-2032

  • Report
  • 149 Pages
  • Global
From
Epigenetics - Global Strategic Business Report - Product Image

Epigenetics - Global Strategic Business Report

  • Report
  • 299 Pages
  • Global
From
Epigenetics Global Market Report 2024 - Product Image

Epigenetics Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Epigenetics Market 2024-2028 - Product Image

Epigenetics Market 2024-2028

  • Report
  • 163 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.